| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Beshar Luke M is a Director at TARA, with reported holdings spanning 2 companies. Recent filings cover 3 purchases and 7 sales. Those positions are worth an estimated $614K at current prices.
Our model assigns Beshar Luke M a below-average insider score of 28/100, based on 3 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -24.1%.
Beshar Luke M's largest disclosed position is in TARA as Director, worth about $614K. Net of sales, the recent Form 4 record there shows accumulation of 30,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2022 | TARA Protara Therapeutics, Inc. | Director | Buy | 10,000 | $3.10 | $31,000.00 | +5.3% | +21.8% | -18.4% | |
| Mar 14, 2022 | TARA Protara Therapeutics, Inc. | Director | Buy | 10,000 | $4.25 | $42,500.00 | +5.6% | -27.1% | -26.1% | |
| Mar 10, 2022 | TARA Protara Therapeutics, Inc. | Director | Buy | 10,000 | $4.46 | $44,555.00 | +6.0% | -22.6% | -27.9% | |
| Nov 29, 2018 | RGNX Regenxbio Inc. | Director | Sale+OE | 12,784 | $65.00 | $830,960.00 | - | - | - | |
| Nov 27, 2018 | RGNX Regenxbio Inc. | Director | Sale+OE | 20,507 | $65.03 | $1,333,518.58 | - | - | - | |
| Nov 20, 2018 | RGNX Regenxbio Inc. | Director | Sale+OE | 33,292 | $60.44 | $2,012,209.04 | - | - | - |